Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer

Background: Estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancers (triple-positive breast cancers, TPBCs) account for 5% to 10% of all breast cancers. The clinical and molecular features of TPBCs remain elusive. In this study, we aim to analyze the multiomics l...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Theranostics
Hoofdauteurs: Zhao, Shen, Liu, Xi-Yu, Jin, Xi, Ma, Ding, Xiao, Yi, Shao, Zhi-Ming, Jiang, Yi-Zhou
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ivyspring International Publisher 2019
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6691389/
https://ncbi.nlm.nih.gov/pubmed/31410192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.35730
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items